Dexamethasone/Cytarabine/Oxaliplatin/Rituximab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of dexamethasone, cytarabine, oxaliplatin and rituximab that can be used to treat diffuse large B-cell lymphoma (DLBCL) and mantle cell lymphoma.

**Synonyms:** - DHAX Plus Rituxan - DHAX Plus Rituximab - DHAX-R - Dexamethasone/Cytarabine/Oxaliplatin Plus Rituximab - Dexamethasone/Cytarabine/Oxaliplatin/Rituximab - R-DHAOx - R-DHAOx (rituximab-abbs) - R-DHAOx (rituximab-arrx) - R-DHAOx (rituximab-blit) - R-DHAOx (rituximab-pvvr) - R-DHAOx (rituximab-rite) - R-DHAOx (rituximab-rixa) - R-DHAOx (rituximab-rixi) - R-DHAX